Human Germline Editing

Human Germline Editing

The National Society of Genetic Counselors (NSGC) recognizes that new and emerging gene-editing techniques may be a means to prevent, ameliorate, or cure genetic disease. As such, the concerns about risk, or unacceptable uses of gene-editing technologies, must be balanced against the benefits that they may bring to individuals and families affected by genetic diseases.

NSGC supports public funding for research that investigates the potential of germline editing in a manner that is regulated, transparent, and equitable. In addition, NSGC supports funding for research into the social and ethical implications of germline editing, including stakeholder and community engagement. Germline editing in human sperm, eggs, or embryos with the intention of creating a pregnancy should be considered only if and when safety and efficacy standards have been established and met. NSGC does not support human germline editing for clinical use at this time. (Adopted 2016, Reaffirmed 2020)

Recent Stories
ASBrS-NSGC Joint Statement of Medical Societies Regarding Genetic Testing Requirements

Raw Data

NSGC Statement on Telehealth

NSGC Executive Office   |   330 North Wabash Avenue, Suite 2000, Chicago, IL 60611   |   312.321.6834   |   nsgc@nsgc.org
© 2021 National Society of Genetic Counselors   |   Privacy Policy   |   Disclaimer   |   Terms and Conditions   |   DMCA Procedures for Removal